Our Services
Medical Information
Helpful Resources
Published on: 4/23/2026
Photobiomodulation uses low-level red and near-infrared light to boost mitochondrial function, reduce inflammation, and early studies suggest it may modestly improve tremor, gait, and mood in Parkinson’s patients with minimal side effects. However clinical trials to date are small, device protocols vary, and long-term, placebo-controlled data are still needed.
There are several factors to consider before adding PBM to your treatment plan; see below for detailed insights on mechanisms, clinical evidence, device selection, safety considerations, and how to navigate the next steps in your healthcare journey.
Parkinson's disease is a progressive neurological disorder that affects movement, often causing tremors, stiffness, and balance problems. While medications and therapies remain the cornerstone of treatment, emerging research suggests that photobiomodulation—also known as red and near-infrared light therapy—may offer additional relief for some symptoms, particularly tremor management.
Photobiomodulation (PBM) uses low-level red or near-infrared light (600–1,000 nm) to stimulate cellular function. Key mechanisms include:
Tremor is one of the most visible and distressing symptoms for people living with Parkinson's. Traditional treatments (medications like levodopa or deep brain stimulation) don't always fully control tremor, and side effects can be a concern. Red light therapy for Parkinson's tremor management is appealing because:
Animal studies have laid the groundwork:
Human data are still emerging, but small pilot studies show promise:
Red light therapy for Parkinson's tremor management is still considered experimental. It may offer benefits with minimal risk, but it won't replace proven treatments. If you're curious:
If you're experiencing new or worsening symptoms and want to better understand what might be causing them, try a free AI-powered symptom checker for Parkinson's Disease to help guide your next conversation with your healthcare provider.
If you ever notice life-threatening or serious changes—such as difficulty breathing, sudden weakness, or a rapid decline in motor function—seek emergency medical attention immediately. Always speak to a doctor about any concerns related to Parkinson's or other health issues.
(References)
* Hamblin MR, et al. Transcranial Photobiomodulation for the Treatment of Parkinson's Disease. J Alzheimers Dis. 2019;70(s1):S79-S91. doi: 10.3233/JAD-190174.
* Ma L, et al. Photobiomodulation for Parkinson's Disease: A Systematic Review. Front Neurosci. 2021 Jul 2;15:683692. doi: 10.3389/fnins.2021.683692. eCollection 2021.
* Johnstone DM, et al. Low-level light therapy for Parkinson's disease: an update on a potential therapeutic option. Expert Rev Neurother. 2019 May;19(5):489-497. doi: 10.1080/14737175.2019.1610497. Epub 2019 Apr 28.
* Liebert A, et al. Transcranial Photobiomodulation for the Treatment of Parkinson's Disease: A Randomized, Controlled, Phase II Study. J Alzheimers Dis. 2022;88(2):775-792. doi: 10.3233/JAD-215714.
* Johnstone DM, et al. Photobiomodulation in Parkinson's disease: a clinical pilot study. J Alzheimers Dis. 2021;83(4):1753-1763. doi: 10.3233/JAD-210173.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.